Drug Information
| Drug General Information | Top | |||
|---|---|---|---|---|
| Drug ID |
D0L5LN
|
|||
| Former ID |
DNC009075
|
|||
| Drug Name |
ANTHRAQUINONE
|
|||
| Synonyms |
84-65-1; 9,10-Anthraquinone; anthracene-9,10-dione; 9,10-Anthracenedione; Anthradione; Hoelite; 9,10-Dioxoanthracene; Corbit; Morkit; 9,10-Anthrachinon; Anthra-9,10-quinone; Anthrapel; 9,10-quinone; Anthrachinon; Caswell No. 052A; Anthraquinone [BSI:ISO]; UNII-030MS0JBDO; NSC 7957; Bis-alkylamino anthraquinone; 9,10-Anthrachinon [Czech]; CCRIS 649; 9,10-Anthracendion; Anthracene, 9,10-dihydro-9,10-dioxo-; CHEBI:40448; HSDB 2074; EINECS 201-549-0; Anthracene-9,10-quinone; EPA Pesticide Chemical Code 122701
Click to Show/Hide
|
|||
| Drug Type |
Small molecular drug
|
|||
| Indication | Discovery agent [ICD-11: N.A.] | Investigative | [1] | |
| Structure |
 |
Download2D MOL |
||
| Formula |
C14H8O2
|
|||
| Canonical SMILES |
C1=CC=C2C(=C1)C(=O)C3=CC=CC=C3C2=O
|
|||
| InChI |
1S/C14H8O2/c15-13-9-5-1-2-6-10(9)14(16)12-8-4-3-7-11(12)13/h1-8H
|
|||
| InChIKey |
RZVHIXYEVGDQDX-UHFFFAOYSA-N
|
|||
| CAS Number |
CAS 84-65-1
|
|||
| PubChem Compound ID | ||||
| ChEBI ID |
CHEBI:40448
|
|||
| Target and Pathway | Top | |||
|---|---|---|---|---|
| Target(s) | M-phase inducer phosphatase 2 (MPIP2) | Target Info | Inhibitor | [1] |
| KEGG Pathway | MAPK signaling pathway | |||
| Cell cycle | ||||
| Progesterone-mediated oocyte maturation | ||||
| MicroRNAs in cancer | ||||
| NetPath Pathway | IL2 Signaling Pathway | |||
| TGF_beta_Receptor Signaling Pathway | ||||
| Wnt Signaling Pathway | ||||
| Pathway Interaction Database | PLK1 signaling events | |||
| FOXM1 transcription factor network | ||||
| p38 signaling mediated by MAPKAP kinases | ||||
| Aurora A signaling | ||||
| Reactome | Cyclin B2 mediated events | |||
| Cyclin A/B1 associated events during G2/M transition | ||||
| Cyclin A:Cdk2-associated events at S phase entry | ||||
| WikiPathways | Senescence and Autophagy in Cancer | |||
| MAPK Signaling Pathway | ||||
| Retinoblastoma (RB) in Cancer | ||||
| Prostate Cancer | ||||
| Integrated Breast Cancer Pathway | ||||
| Integrated Cancer pathway | ||||
| Mitotic G2-G2/M phases | ||||
| Cell Cycle | ||||
| References | Top | |||
|---|---|---|---|---|
| REF 1 | Bioactivities of simplified adociaquinone B and naphthoquinone derivatives against Cdc25B, MKP-1, and MKP-3 phosphatases. Bioorg Med Chem. 2009 Mar 15;17(6):2276-81. | |||
If You Find Any Error in Data or Bug in Web Service, Please Kindly Report It to Dr. Zhou and Dr. Zhang.